NO801855L - Fremgangsmaate ved fremstilling av nye enkafalinderivater - Google Patents
Fremgangsmaate ved fremstilling av nye enkafalinderivaterInfo
- Publication number
- NO801855L NO801855L NO801855A NO801855A NO801855L NO 801855 L NO801855 L NO 801855L NO 801855 A NO801855 A NO 801855A NO 801855 A NO801855 A NO 801855A NO 801855 L NO801855 L NO 801855L
- Authority
- NO
- Norway
- Prior art keywords
- encapal
- ingredients
- procedure
- preparation
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5095079A | 1979-06-21 | 1979-06-21 | |
| US06/130,431 US4341698A (en) | 1979-06-21 | 1980-03-14 | Enkaphalin derivatives |
| AU91877/82A AU559278B2 (en) | 1979-06-21 | 1982-12-24 | Piperazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO801855L true NO801855L (no) | 1980-12-22 |
Family
ID=36764304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO801855A NO801855L (no) | 1979-06-21 | 1980-06-20 | Fremgangsmaate ved fremstilling av nye enkafalinderivater |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4341698A (no) |
| AU (1) | AU559278B2 (no) |
| CA (1) | CA1161838A (no) |
| CH (2) | CH645363A5 (no) |
| DE (1) | DE3022401A1 (no) |
| DK (1) | DK265780A (no) |
| ES (1) | ES492566A0 (no) |
| FR (2) | FR2459236A1 (no) |
| GB (3) | GB2051821B (no) |
| IE (1) | IE49834B1 (no) |
| IL (1) | IL60245A (no) |
| IT (1) | IT1148277B (no) |
| NL (1) | NL8003580A (no) |
| NO (1) | NO801855L (no) |
| NZ (1) | NZ193934A (no) |
| PH (1) | PH19222A (no) |
| SE (3) | SE447250B (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
| US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
| NZ500353A (en) | 1997-04-14 | 2002-02-01 | Cor Therapeutics Inc | Cyclic diaza compounds that are selective inhibitors of factor Xa |
| EP0977773A1 (en) | 1997-04-14 | 2000-02-09 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| US6133256A (en) * | 1997-04-14 | 2000-10-17 | Cor Therapeutics Inc | Selective factor Xa inhibitors |
| US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
| US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US9597314B2 (en) | 2005-03-22 | 2017-03-21 | Azevan Pharmaceuticals, Inc. | Beta-lactamylalkanoic acids for treating premenstrual disorders |
| AU2006270039B2 (en) | 2005-07-19 | 2013-07-04 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| US7964181B2 (en) * | 2006-03-30 | 2011-06-21 | Palatin Technologies, Inc. | Amino acid surrogates for peptidic constructs |
| DK2001518T3 (da) * | 2006-03-30 | 2013-10-07 | Palatin Technologies Inc | Cykliske natriuretiske peptidfremstillinger |
| US8580746B2 (en) | 2006-03-30 | 2013-11-12 | Palatin Technologies, Inc. | Amide linkage cyclic natriuretic peptide constructs |
| US8114844B2 (en) * | 2006-03-30 | 2012-02-14 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptidomimetics |
| AU2007233105B2 (en) * | 2006-03-30 | 2013-05-16 | Palatin Technologies, Inc. | Amino acid surrogates for peptidic constructs |
| AU2007233123A1 (en) * | 2006-03-30 | 2007-10-11 | Palatin Technologies, Inc. | Linear natriuretic peptide constructs |
| CN101563319B (zh) * | 2006-12-19 | 2012-09-05 | 弗·哈夫曼-拉罗切有限公司 | 杂芳基吡咯烷基和哌啶基甲酮衍生物 |
| BRPI0914160A2 (pt) * | 2008-06-18 | 2019-09-24 | Hoffmann La Roche | aril cetona como mri |
| CN103269584B (zh) | 2010-07-01 | 2017-05-03 | 阿泽凡药物公司 | 用于治疗创伤后应激障碍的方法 |
| MX2016012645A (es) | 2014-03-28 | 2017-01-11 | Azevan Pharmaceuticals Inc | Composiciones y metodos para tratar enfermedades neurodegenerativas. |
| WO2019055913A1 (en) | 2017-09-15 | 2019-03-21 | Azevan Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN INJURY |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2604845A1 (de) * | 1976-02-07 | 1977-08-18 | Knoll Ag | Neue piperazinderivate |
| US4254107A (en) * | 1979-11-27 | 1981-03-03 | Merck & Co., Inc. | Long-lasting agonists of enkephalin |
-
1980
- 1980-03-14 US US06/130,431 patent/US4341698A/en not_active Expired - Lifetime
- 1980-06-04 CA CA000353383A patent/CA1161838A/en not_active Expired
- 1980-06-04 IE IE1152/80A patent/IE49834B1/en not_active IP Right Cessation
- 1980-06-04 NZ NZ193934A patent/NZ193934A/xx unknown
- 1980-06-06 IL IL60245A patent/IL60245A/xx unknown
- 1980-06-06 SE SE8004254A patent/SE447250B/sv not_active IP Right Cessation
- 1980-06-14 DE DE19803022401 patent/DE3022401A1/de not_active Withdrawn
- 1980-06-16 PH PH24144A patent/PH19222A/en unknown
- 1980-06-17 CH CH469880A patent/CH645363A5/de not_active IP Right Cessation
- 1980-06-17 CH CH1248/84A patent/CH648835A5/de not_active IP Right Cessation
- 1980-06-18 ES ES492566A patent/ES492566A0/es active Granted
- 1980-06-18 GB GB8019903A patent/GB2051821B/en not_active Expired
- 1980-06-20 DK DK265780A patent/DK265780A/da not_active Application Discontinuation
- 1980-06-20 FR FR8013795A patent/FR2459236A1/fr active Granted
- 1980-06-20 NL NL8003580A patent/NL8003580A/nl not_active Application Discontinuation
- 1980-06-20 NO NO801855A patent/NO801855L/no unknown
- 1980-06-20 IT IT49032/80A patent/IT1148277B/it active
-
1981
- 1981-02-04 FR FR8102171A patent/FR2473042A1/fr active Granted
-
1982
- 1982-09-10 GB GB08225842A patent/GB2106515B/en not_active Expired
- 1982-09-10 GB GB08225828A patent/GB2132605B/en not_active Expired
- 1982-12-24 AU AU91877/82A patent/AU559278B2/en not_active Ceased
-
1985
- 1985-02-22 SE SE8500877A patent/SE460540B/sv not_active IP Right Cessation
- 1985-02-22 SE SE8500878A patent/SE460541B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB2051821A (en) | 1981-01-21 |
| SE8500877D0 (sv) | 1985-02-22 |
| FR2473042A1 (fr) | 1981-07-10 |
| FR2459236A1 (fr) | 1981-01-09 |
| AU9187782A (en) | 1983-04-21 |
| US4341698A (en) | 1982-07-27 |
| FR2473042B1 (no) | 1983-07-01 |
| GB2132605A (en) | 1984-07-11 |
| CH648835A5 (de) | 1985-04-15 |
| SE8500877L (sv) | 1985-02-22 |
| PH19222A (en) | 1986-02-12 |
| SE460541B (sv) | 1989-10-23 |
| IT8049032A0 (it) | 1980-06-20 |
| CA1161838A (en) | 1984-02-07 |
| GB2106515A (en) | 1983-04-13 |
| IT1148277B (it) | 1986-11-26 |
| IE801152L (en) | 1980-12-21 |
| NL8003580A (nl) | 1980-12-23 |
| GB2132605B (en) | 1985-01-03 |
| GB2106515B (en) | 1983-11-23 |
| AU559278B2 (en) | 1987-03-05 |
| ES8105720A1 (es) | 1981-06-16 |
| IE49834B1 (en) | 1985-12-25 |
| GB2051821B (en) | 1983-04-27 |
| SE8500878D0 (sv) | 1985-02-22 |
| CH645363A5 (de) | 1984-09-28 |
| SE8004254L (sv) | 1980-12-22 |
| FR2459236B1 (no) | 1984-01-06 |
| ES492566A0 (es) | 1981-06-16 |
| SE447250B (sv) | 1986-11-03 |
| DK265780A (da) | 1980-12-22 |
| IL60245A (en) | 1985-08-30 |
| SE460540B (sv) | 1989-10-23 |
| NZ193934A (en) | 1983-02-15 |
| DE3022401A1 (de) | 1981-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO801015L (no) | Fremgangsmaate ved fremstilling av nye piperidinderivater | |
| NO801014L (no) | Fremgangsmaate for fremstilling av nye piperidinderivater | |
| NO803868L (no) | Fremgangsmaate ved fremstilling av nye kinazolinderivater | |
| NO792760L (no) | Fremgangsmaate ved fremstilling av nye nafthydrinderivater | |
| NO801155L (no) | Fremgangsmaate ved fremstilling av acyl-carnitinamider | |
| NO794327L (no) | Fremgangsmaate ved fremstilling av nye peptidylargininaldehyd-derivater. | |
| NO801855L (no) | Fremgangsmaate ved fremstilling av nye enkafalinderivater | |
| NO792823L (no) | Fremgangsmaate ved fremstilling av nye arginiamidderivater | |
| NO800650L (no) | Fremgangsmaate ved fremstilling av nye indolderivater | |
| NO802913L (no) | Fremgangsmaate ved fremstilling av cephalosporinforbindelse | |
| NO142240C (no) | Fremgangsmaate ved fremstilling av fiskekjoettekstrakt | |
| NO791831L (no) | Fremgangsmaate for fremstilling av aminotiazoler | |
| NO803935L (no) | Fremgangsmaate ved fremstilling av nye 2-acylaminomethyl-1,4-benzodiazepiner | |
| DK4280A (da) | Fremgangsmaade til fremstilling af pleuromutilinderivater | |
| NO150892C (no) | Fremgangsmaate ved fremstilling av slipemasse | |
| NO800338L (no) | Fremgangsmaate ved fremstilling av nye 4-(nafthylmethyl)piperidinderivater. | |
| NO803247L (no) | R fremgangsmaate ved fremstilling av nye pyridothienotriazine | |
| NO802402L (no) | R fremgangsmaate ved fremstilling av nye halovincamonderivate | |
| NO802834L (no) | Fremgangsmaate ved fremstilling av 2-amino-3-benzoyl-fenylacetamider | |
| NO803044L (no) | Fremgangsmaate ved fremstilling av nye derivater av 1,2,4-oxadiazolin-5-on | |
| NO801982L (no) | Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater | |
| NO801179L (no) | Fremgangsmaate ved fremstilling av 2`,6`-dialkyl-n-alkoxymethyl-2-klor-acetanilider | |
| NO147310C (no) | Fremgangsmaate for fremstilling av substituerte antitumorantracykliner | |
| NO802435L (no) | Fremgangsmaate til fremstilling av tetrahydrokinolinderivater | |
| NO791220L (no) | Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner |